Department of Dermatology, Ankara City Hospital, Ankara, Turkey.
Department of Basic Oncology, Hacettepe University, Cancer Institute, Ankara, Turkey.
Int J Clin Pract. 2021 Mar;75(3):e14024. doi: 10.1111/ijcp.14024. Epub 2021 Jan 25.
Vitiligo is an autoimmune disease characterised by acquired loss of melanocytes. Although the pathogenesis of vitiligo remains unknown, oxidative stress and autoimmune dysregulations are considered to play a role.
The aim of this study was to evaluate the HLA profile and total antioxidant capacity (TAC) and their relationship to clinical characteristic of vitiligo patients.
Ninety-one vitiligo patients and 100 healthy controls were included in the study. We analysed HLA allele frequencies using sequence-specific oligonucleotide Prob (SSOP) method. Serum total antioxidant capacity (TAC) levels were measured and compared between vitiligo patients and controls.
HLA-A02 allele frequency was increased (OR = 1.6, CI = 1.12-2.24, P = .009), HLA-A11 (OR = 0.46, CI = 0.32-0.91, P = .019) and HLA-DRB101 (OR = 0.39, CI = 0.16-0.92, P = .029) frequencies were decreased in vitiligo patients. HLA-A02 allele especially increased the risk of late onset (Vitiligo onset >30 years of age) vitiligo (OR:3.67, 95% CI: 1.63-8.26, P = .002). Serum TAC levels were similar between vitiligo patients and healthy controls but TAC levels were significantly lower in patients who did not have an HLA-DRB1*01 allele (1.52 vs 1.61, P = .033).
Our study showed that HLA-A02 increases, HLA-A11 and HLA-DRB1*01 decreases vitiligo susceptibility in Turkish patients as well as a possible relationship between HLA and TAC.
白癜风是一种自身免疫性疾病,其特征是黑色素细胞获得性丧失。虽然白癜风的发病机制尚不清楚,但氧化应激和自身免疫失调被认为起作用。
本研究旨在评估 HLA 谱和总抗氧化能力(TAC)及其与白癜风患者临床特征的关系。
本研究纳入了 91 名白癜风患者和 100 名健康对照者。我们使用序列特异性寡核苷酸 Prob(SSOP)方法分析 HLA 等位基因频率。测量并比较白癜风患者和对照组的血清总抗氧化能力(TAC)水平。
HLA-A02 等位基因频率增加(OR=1.6,CI=1.12-2.24,P=0.009),HLA-A11(OR=0.46,CI=0.32-0.91,P=0.019)和 HLA-DRB101(OR=0.39,CI=0.16-0.92,P=0.029)频率降低。HLA-A02 等位基因特别增加了晚发性(白癜风发病年龄>30 岁)白癜风的发病风险(OR:3.67,95%CI:1.63-8.26,P=0.002)。白癜风患者和健康对照组的血清 TAC 水平相似,但没有 HLA-DRB1*01 等位基因的患者 TAC 水平明显较低(1.52 与 1.61,P=0.033)。
我们的研究表明,HLA-A02 增加,HLA-A11 和 HLA-DRB1*01 减少了土耳其患者的白癜风易感性,以及 HLA 和 TAC 之间可能存在的关系。